ELIZABETH MORPHIS: Open Payments
NPI 1730245069 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 9 payments from 8 companies in 2025. Trend: 2023 $237 · 2024 $257 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Seqirus USA Inc | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| bioMerieux Inc | 1 | $14 |
| SANOFI PASTEUR INC. | 1 | $14 |
| Corium, LLC | 1 | $12 |
Products named: Qelbree, Flucelvax, Onyda XR, BEXSERO, ROTATEQ, BIOFIRE SPOTFIRE Control Station, VAXELIS, Azstarys.
Industry payments across SC — which companies pay providers there.
